NAPO - Novel Approach for Oligospermia (NAPO)
Novel Approach for Oligospermia (NAPO): A Randomized Controlled Trial
Sponsor: Martin Blomberg Jensen
A PHASE1/PHASE2 clinical study on Infertility, Male, this trial is completed. The trial is conducted by Martin Blomberg Jensen and has accumulated 8 data snapshots since 2024. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
8 versions recorded-
Jan 2026 — Present [monthly]
Completed PHASE1/PHASE2
Status: Active Not Recruiting → Completed
-
Jun 2025 — Jan 2026 [monthly]
Active Not Recruiting PHASE1/PHASE2
-
Mar 2025 — Jun 2025 [monthly]
Active Not Recruiting PHASE1/PHASE2
Status: Recruiting → Active Not Recruiting
-
Jan 2025 — Mar 2025 [monthly]
Recruiting PHASE1/PHASE2
Status: Active Not Recruiting → Recruiting
-
Dec 2024 — Jan 2025 [monthly]
Active Not Recruiting PHASE1/PHASE2
Status: Not Yet Recruiting → Active Not Recruiting
▶ Show 3 earlier versions
-
Sep 2024 — Dec 2024 [monthly]
Not Yet Recruiting PHASE1/PHASE2
-
Jul 2024 — Sep 2024 [monthly]
Not Yet Recruiting PHASE1/PHASE2
Phase: PHASE1_PHASE2 → PHASE1/PHASE2
-
Apr 2024 — Jul 2024 [monthly]
Not Yet Recruiting PHASE1_PHASE2
First recorded
Mar 2024
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Martin Blomberg Jensen
For direct contact, visit the study record on ClinicalTrials.gov .